The OIS Index of ophthalmic stocks gained 5.2% in October, posting its first month of positive performance since June. The index lagged the biotech sector (+7.7%) and outperformed an index of medical device stocks (+0.8%) and the broader US stock market (+2.0%).
The largest positive contributor was STAAR Surgical (+27.2%), driven by strong Q3 results. IVERIC bio tripled in value on positive Phase 2b data for Zimura in geographic atrophy secondary to dry age-related macular degeneratio. Clearside Biomedical doubled on an announced license agreement with Bausch Health. Other big movers included Adverum (+33.4%), EyePoint (+24.9%), and Apellis (+22.0%).
For more, visit https://ois.net/ois-index/